» Articles » PMID: 19680140

Selective Deposition of 4-repeat Tau in Cerebral Infarcts

Overview
Specialties Neurology
Pathology
Date 2009 Aug 15
PMID 19680140
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The tau deposits found in neurodegenerative diseases are classified based on their isoforms, that is, 3-repeat (3R) tau and 4-repeat (4R) tau. These isoforms are distinguishable using the antibodies RD3 and RD4, respectively, and Gallyas (Gal) and Campbell-Switzer (CS) silver staining methods, respectively. Tau is also deposited in cerebral infarcts. To characterize the tau profile in these lesions, 21 brains from autopsied patients with cerebral infarcts were analyzed using immunohistochemistry with RD3, RD4, and the anti-paired helical filament antibody AT8 and with Gal and CS staining; all of these techniques identify Alzheimer disease-type neurofibrillary tangles. Fluorescence labeling followed by silver staining in mirror-section pairs was also used to compare the staining patterns. Neurons in and around ischemic foci exhibited the 4R-tau epitope until 34 days postinfarction; argyrophilia with Gal staining persisted longer. The 4R-tau/Gal-positive neurons were negative for 3R-tau and AT8 epitopes and lacked fibrillary structures and argyrophilia by CS staining; they are, therefore, distinct from neurons with neurofibrillary tangles. Positivity for 4R tau/Gal and negativity for 3R tau/CS were also seen in astrocytes and microglia around infarcts. Although this staining profile is characteristic of degenerative processes with 4R-tau deposition, lack of AT8 immunoreactivity and of fibrillary structures in neurons, astrocytes, and microglia indicates that selective 4R-tau deposition represents a stage without tau phosphorylation or fibril formation in cerebral infarcts.

Citing Articles

Classification of diseases with accumulation of Tau protein.

Kovacs G, Ghetti B, Goedert M Neuropathol Appl Neurobiol. 2022; 48(3):e12792.

PMID: 35064600 PMC: 9352145. DOI: 10.1111/nan.12792.


Multimodal F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network.

Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu M J Nucl Med. 2019; 61(2):263-269.

PMID: 31350322 PMC: 8801947. DOI: 10.2967/jnumed.118.225508.


Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: The Hisayama study.

Hamasaki H, Honda H, Suzuki S, Shijo M, Ohara T, Hatabe Y Alzheimers Dement (Amst). 2019; 11:415-423.

PMID: 31206007 PMC: 6558096. DOI: 10.1016/j.dadm.2019.04.008.


How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.

Ebashi M, Ito Y, Uematsu M, Nakamura A, Hirokawa K, Kamei S Acta Neuropathol Commun. 2019; 7(1):71.

PMID: 31060611 PMC: 6503360. DOI: 10.1186/s40478-019-0708-4.


Visualization of ischemic stroke-related changes on F-THK-5351 positron emission tomography.

Huang K, Hsu J, Lin K, Chang C, Wu Y, Chang T EJNMMI Res. 2018; 8(1):62.

PMID: 30014313 PMC: 6047954. DOI: 10.1186/s13550-018-0417-1.